<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 12.4: Recurring Pregnancy Loss (RPL): Root Cause Investigation</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP TEAL theme for Complex Cases */
        .module-header {
            background: linear-gradient(135deg, #0f172a 0%, #334155 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #334155;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #334155;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f8fafc;
            border: 2px solid #334155;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f1f5f9 0%, #e2e8f0 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #cbd5e1;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #334155;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #334155;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e293b;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #475569;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e293b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs & Highlights */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #334155;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fde68a 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #e2e8f0;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #1e293b;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #334155 0%, #475569 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e2e8f0;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #64748b, #334155);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #1e293b 0%, #334155 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Comparison Table */
        .comparison-table-container {
            overflow-x: auto;
            margin: 30px 0;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            background: white;
            border-radius: 12px;
            overflow: hidden;
            box-shadow: 0 4px 15px rgba(0,0,0,0.05);
        }

        th {
            background: #334155;
            color: white;
            padding: 15px;
            text-align: left;
            font-size: 14px;
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #e2e8f0;
            font-size: 15px;
            color: #475569;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Principle Cards */
        .principle-card {
            background: linear-gradient(to right, #f8fafc, #ffffff);
            border-left: 5px solid #334155;
            padding: 24px 28px;
            margin-bottom: 18px;
            border-radius: 0 14px 14px 0;
            box-shadow: 0 2px 10px rgba(0, 0, 0, 0.04);
        }

        .principle-title {
            font-weight: 700;
            color: #1e293b;
            margin: 0 0 10px 0;
            font-size: 17px;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #334155;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #1e293b;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #f1f5f9;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & Footer */
        .takeaways-box {
            background: #f1f5f9;
            padding: 22px 25px;
            margin-top: 35px;
            border-radius: 8px;
            border: 1px solid #cbd5e1;
        }

        .references-box {
            margin-top: 40px;
            padding: 25px;
            background: #fff;
            border: 1px solid #eee;
            border-radius: 12px;
            font-size: 14px;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 12: Special Populations & Complex Cases</p>
            <h1 class="lesson-title">Lesson 12.4: Recurring Pregnancy Loss (RPL): Root Cause Investigation</h1>
            <div class="lesson-meta">
                <span class="meta-item">32 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>Redefining RPL</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Genetic & Chromosomal Drivers</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Anatomical & Uterine Factors</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Immunological & Clotting Factors</a></li>
                <li><a href="#section5"><span class="section-num">5</span>The P.R.I.M.E. Protocolâ„¢ in RPL</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Male Factor: The Hidden Link</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between the clinical definition of RPL and the proactive coaching approach.</li>
                <li>Identify the top five physiological root causes of recurring loss, including Antiphospholipid Syndrome (APS).</li>
                <li>Apply the P.R.I.M.E. Protocolâ„¢ to investigate metabolic and inflammatory barriers to pregnancy maintenance.</li>
                <li>Explain the role of sperm DNA fragmentation in early pregnancy loss.</li>
                <li>Formulate a comprehensive testing checklist to empower clients in clinical conversations.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>From "Bad Luck" to Biological Blueprint</h3>
            <p>Recurring Pregnancy Loss (RPL) is one of the most psychologically taxing experiences a client can endure. Historically, conventional medicine didn't begin investigations until a client suffered three consecutive losses. Today, we know that <span class="highlight">waiting for a third loss is clinically outdated and emotionally negligent</span>. As an expert coach, your role is to pivot the narrative from "random chance" to a detailed investigation of the biological environment. This lesson provides the advanced physiological framework to uncover why the body is struggling to sustain life.</p>
        </div>

        <div class="key-terms-box">
            <p class="box-label">ðŸ”¬ Key Terms to Know</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Aneuploidy</p>
                    <p class="definition">An abnormal number of chromosomes in a cell, which is the leading cause of first-trimester miscarriages.</p>
                </div>
                <div class="term-item">
                    <p class="term">Antiphospholipid Syndrome (APS)</p>
                    <p class="definition">An autoimmune disorder where the body creates antibodies that attack proteins on the surface of blood cells, leading to clots in the placenta.</p>
                </div>
                <div class="term-item">
                    <p class="term">Balanced Translocation</p>
                    <p class="definition">A condition where a parent has the correct amount of genetic material, but it is rearranged, increasing the risk of unbalanced embryos.</p>
                </div>
                <div class="term-item">
                    <p class="term">Chronic Endometritis</p>
                    <p class="definition">A persistent, low-grade inflammation of the uterine lining, often asymptomatic but highly disruptive to implantation.</p>
                </div>
            </div>
        </div>

        <h2 id="section1">Redefining RPL: The Statistics of Loss</h2>
        <p>While a single miscarriage occurs in approximately 15-25% of all recognized pregnancies, Recurring Pregnancy Loss is a distinct clinical entity. According to the American Society for Reproductive Medicine (ASRM), RPL is defined as <span class="highlight">two or more failed clinical pregnancies</span>. </p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">1-2%</div>
                    <div class="stat-label">Couples Affected by RPL</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">50%</div>
                    <div class="stat-label">Cases Unexplained (Conv.)</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Attributed to APS</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">75%</div>
                    <div class="stat-label">Success Rate with Support</div>
                </div>
            </div>
        </div>

        <p>A 2021 study in <i>The Lancet</i> highlighted that even when no cause is found, the probability of a successful next pregnancy remains high (roughly 75%) with supportive care. However, for the professional coach, "unexplained" usually means "un-investigated." By using <span class="highlight">Physiological Profiling</span>, we look for the subtle sub-clinical markers that conventional screenings often miss.</p>

        <h2 id="section2">Genetic & Chromosomal Drivers</h2>
        <p>Chromosomal abnormalities in the embryo account for approximately 60% of sporadic miscarriages. In RPL, however, we must look at the parents' genetic contributions. While the embryo may be aneuploid, the *reason* for consistent aneuploidy may be related to gamete quality (egg/sperm) or parental genetics.</p>
        
        <p>One critical investigation is <b>Parental Karyotyping</b>. In about 3-5% of couples with RPL, one partner carries a balanced chromosomal translocation. While the parent is healthy, their gametes often end up with "unbalanced" material, leading to non-viable pregnancies. As a coach, if a client has had multiple losses, suggesting a karyotype test is a foundational step in <span class="highlight">Physiological Profiling</span>.</p>

        <h2 id="section3">Anatomical & Uterine Factors</h2>
        <p>The "soil" must be prepared for the "seed." Anatomical issues can prevent proper blood flow to the placenta or restrict the space needed for a developing fetus. These include:</p>
        <ul class="content-list">
            <li><b>Uterine Septum:</b> A wedge of tissue dividing the uterus. This tissue has poor blood supply; if an embryo implants there, it often fails.</li>
            <li><b>Ashermanâ€™s Syndrome:</b> Intrauterine adhesions (scar tissue) usually resulting from previous D&Cs or infections.</li>
            <li><b>Submucosal Fibroids:</b> These grow into the uterine cavity and can trigger inflammatory cytokines that prevent stable implantation.</li>
        </ul>

        <div class="comparison-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Factor</th>
                        <th>Mechanism of Loss</th>
                        <th>Diagnostic Tool</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Uterine Septum</td>
                        <td>Avascular tissue prevents placental development</td>
                        <td>3D Ultrasound / Hysteroscopy</td>
                    </tr>
                    <tr>
                        <td>Chronic Endometritis</td>
                        <td>Inflammatory environment (Leukocytes)</td>
                        <td>Endometrial Biopsy (CD138)</td>
                    </tr>
                    <tr>
                        <td>Luteal Phase Defect</td>
                        <td>Insufficient progesterone to maintain lining</td>
                        <td>7-Day Post-Ovulation Progesterone</td>
                    </tr>
                    <tr>
                        <td>APS</td>
                        <td>Placental micro-clots and infarction</td>
                        <td>Lupus Anticoagulant / Anticardiolipin</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section4">Immunological & Clotting Factors</h2>
        <p>This is where the P.R.I.M.E. Protocolâ„¢ pillar of <span class="highlight">Inflammatory Inhibition</span> becomes paramount. The body must undergo a state of "immune tolerance" to accept the semi-allograft (the embryo, which contains 50% foreign DNA from the father).</p>

        <p><b>Antiphospholipid Syndrome (APS):</b> This is the most treatable cause of RPL. The presence of these antibodies causes the blood to "stick" and clot within the tiny vessels of the developing placenta. Without adequate blood flow, the pregnancy ceases. Standard medical intervention involves low-dose aspirin and heparin, but coaching supports this by reducing systemic inflammation through diet.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Unexplained" Loss</p>
                    <p class="subtitle">Applying Physiological Profiling & Inflammatory Inhibition</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Elena, 33</h4>
                        <p>History: 3 miscarriages (all between 6-8 weeks). All tests "normal" per her OBGYN.</p>
                    </div>
                </div>
                <p><b>Intervention:</b> Elena's coach noted she had Raynaudâ€™s (cold fingers/toes) and a family history of clots. They suggested a deep-dive clotting panel (Physiological Profiling). Elena tested positive for <i>Factor V Leiden</i> and <i>MTHFR</i> (homozygous).</p>
                <p><b>Outcome:</b> By switching to methylated folate (Metabolic Mapping) and working with a hematologist for blood thinners, Elena successfully carried her fourth pregnancy to term. The coach focused on an anti-inflammatory protocol to support vascular health.</p>
            </div>
        </div>

        <h2 id="section5">The P.R.I.M.E. Protocolâ„¢ in RPL Investigation</h2>
        <p>When the standard tests come back "normal," we turn to the P.R.I.M.E. methodology to find the functional imbalances.</p>

        <div class="principle-card">
            <p class="principle-title">P - Physiological Profiling</p>
            <p class="principle-text">We look beyond basic CBCs. We investigate Thyroid Peroxidase (TPO) antibodies. A 2015 study showed that women with thyroid antibodies have a 2-3x higher risk of miscarriage, even if their TSH is "normal."</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">I - Inflammatory Inhibition</p>
            <p class="principle-text">Chronic Endometritis (CE) is present in up to 30% of RPL cases. It is often a silent infection. We address this by supporting the <b>Uterine Microbiome</b> (M - Microbiome Mapping) and reducing systemic "inflammaging."</p>
        </div>

        <div class="principle-card">
            <p class="principle-title">M - Metabolic Mapping</p>
            <p class="principle-text">Insulin resistance is a major driver of loss. High insulin levels increase PAI-1 (Plasminogen Activator Inhibitor), which promotes clotting at the implantation site. We optimize glucose stability to protect the pregnancy.</p>
        </div>

        <h2 id="section6">Male Factor: The Hidden Link</h2>
        <p>For too long, RPL was viewed solely as a "female problem." However, <span class="highlight">Sperm DNA Fragmentation</span> is now recognized as a significant contributor to early loss. If the sperm's DNA is "broken" (fragmented), the embryo may have enough energy to divide for a few days, but it will eventually reach a "genomic block" where it can no longer progress, leading to a miscarriage around weeks 5-9.</p>

        <p>A meta-analysis of 16 studies found that high sperm DNA fragmentation doubled the risk of miscarriage. As a coach, you must insist on a <b>Sperm DNA Fragmentation Index (DFI)</b> test, not just a standard semen analysis, for any couple experiencing RPL.</p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your clinical knowledge on RPL root causes.</p>
            
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">A client has had two losses at 7 weeks. Her TSH is 3.2 mIU/L, which her doctor says is "fine." Why might you suggest further investigation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">In the context of RPL, many experts (and ASRM guidelines) suggest TSH should be below 2.5 mIU/L. Furthermore, we need to check for TPO antibodies (Physiological Profiling), as thyroid autoimmunity itself increases loss risk regardless of TSH.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">What is the primary mechanism by which Antiphospholipid Syndrome (APS) causes pregnancy loss?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">APS causes a hypercoagulable state (thick blood), leading to the formation of micro-clots in the placental vasculature, which prevents the fetus from receiving oxygen and nutrients.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways for the Practitioner</p>
            <ul>
                <li><b>Advocate Early:</b> Transition clients to investigation after 2 losses, rather than waiting for 3.</li>
                <li><b>Screen Both Partners:</b> Always include Sperm DNA Fragmentation and Parental Karyotyping in the investigation phase.</li>
                <li><b>Check the "Soil":</b> Ensure an evaluation of the uterine lining for chronic endometritis or anatomical defects (Septum).</li>
                <li><b>Metabolic Matters:</b> Optimize insulin sensitivity and thyroid function to the "fertility range," not just the "lab range."</li>
                <li><b>Immune & Blood:</b> Screen for APS and thrombophilias as these are highly treatable causes of recurring loss.</li>
            </ul>
        </div>

        <div class="references-box">
            <p class="box-label">References & Further Reading</p>
            <ul style="list-style: none; padding: 0;">
                <li>Practice Committee of the ASRM. (2020). "Evaluation and treatment of recurrent pregnancy loss: a committee opinion." <i>Fertility and Sterility</i>.</li>
                <li>Bender Atik et al. (2018). "ESHRE guideline: recurrent pregnancy loss." <i>Human Reproduction Open</i>.</li>
                <li>Kolte et al. (2021). "The global prevalence of recurrent pregnancy loss: a systematic review and meta-analysis." <i>The Lancet</i>.</li>
                <li>Pillarisetty et al. (2022). "Recurrent Pregnancy Loss: Root Cause Analysis and Management." <i>StatPearls Publishing</i>.</li>
                <li>McQueen et al. (2015). "Thyroid autoimmunity and recurrent pregnancy loss." <i>Fertility and Sterility</i>.</li>
                <li>Robinson et al. (2012). "The effect of sperm DNA fragmentation on miscarriage rates: a meta-analysis." <i>Human Reproduction</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Â© 2024</p>
            <p class="copyright">Certified Fertility & Prenatal Coach Program | Module 12 | Lesson 4</p>
        </footer>
    </div>
</body>

</html>